'Pac-Man' gene implicated in Alzheimer's disease

July 26, 2016
Diagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.

A gene that protects the brain from the harmful build-up of amyloid-beta, one of the causative proteins implicated in Alzheimer's disease, has been identified as a new target for therapy by NeuRA researchers.

The recent study, led by Dr Scott Kim, revealed that the ABCA7 gene plays a protective role in the brain by "gobbling up" amyloid-beta. It will be published in the Journal of Alzheimer's Disease.

If amyloid-beta proteins are left unchecked, they form masses that are toxic to the in the brain, contributing to the development of Alzheimer's disease.

The study provides compelling evidence, using animal models and human brain tissue, that ABCA7 plays a crucial role in supporting the that devour amyloid-beta proteins.

Two of the key suspected causes of Alzheimer's disease is that there is either a fault with the creation of amyloid-beta proteins or with the removal of amyloid-beta proteins from the brain. This study has shown that the lack of ABCA7 function contributes to the development of pathology associated with Alzheimer's disease and revealed the mechanism by which this may occur.

"In healthy people, the scavenger cells of the brain 'chomp up' excess amyloid-beta proteins, just like Pac-Man. However, in people with an aberration in ABCA7, the scavenger cells cannot do this properly," says Dr Kim.

This insight offers new hope for developing therapies that help to control the build-up of amyloid-beta in the and reduce a person's likelihood of developing Alzheimer's disease.

"The recent discovery of ABCA7 as a new candidate gene for Alzheimer's disease paves the way for new and innovative approaches to tackling the disease," says Dr Kim.

Explore further: Cannabinoids remove plaque-forming Alzheimer's proteins from brain cells

Related Stories

Cannabinoids remove plaque-forming Alzheimer's proteins from brain cells

June 29, 2016
Salk Institute scientists have found preliminary evidence that tetrahydrocannabinol (THC) and other compounds found in marijuana can promote the cellular removal of amyloid beta, a toxic protein associated with Alzheimer's ...

Three Alzheimer's genetic risk factors linked to immune cell dysfunction

July 20, 2016
People with a variant copy of the TREM2 gene have an increased risk of developing Alzheimer's disease, but researchers are only beginning to understand why.

Alzheimer's genetics point to new research direction

June 27, 2016
A University of Adelaide analysis of genetic mutations which cause early-onset Alzheimer's disease suggests a new focus for research into the causes of the disease.

Designer protein gives new hope to scientists studying Alzheimer's disease

July 22, 2016
A new protein which will help scientists to understand why nerve cells die in people with Alzheimer's disease has been designed in a University of Sussex laboratory.

Alzheimer's more versatile than previously known

March 7, 2016
Accumulation of the substance amyloid beta in the brain impairs the memory and cognitive ability in people with Alzheimer's. New findings from Lund University in Sweden show that the cause of amyloid beta pathology might ...

Genetically engineered mice suggest new model for how Alzheimer's causes dementia

July 4, 2016
Using a novel, newly developed mouse model that mimics the development of Alzheimer's disease in humans, Johns Hopkins researchers say they have been able to determine that a one-two punch of major biological "insults" must ...

Recommended for you

Delayed word processing could predict patients' potential to develop Alzheimer's disease

October 20, 2017
A delayed neurological response to processing the written word could be an indicator that a patient with mild memory problems is at an increased risk of developing Alzheimer's disease, research led by the University of Birmingham ...

PET scans for Alzheimer's could bring benefit to more patients

October 19, 2017
An imaging tool honed to spot rogue proteins in the brain could benefit some patients with suspected Alzheimer's, according to a new study.

One step closer toward a treatment for Alzheimer's disease?

October 18, 2017
Scientists at the Massachusetts General Hospital (MGH), in collaboration with colleagues at the University California, San Diego (UCSD), have characterized a new class of drugs as potential therapeutics for Alzheimer's disease ...

New mechanism detected in Alzheimer's disease

October 13, 2017
McGill University researchers have discovered a cellular mechanism that may contribute to the breakdown of communication between neurons in Alzheimer's disease.

Neuroscientists identify genetic changes in microglia in a mouse model of neurodegeneration and Alzheimer's disease

October 13, 2017
Microglia, immune cells that act as the central nervous system's damage sensors, have recently been implicated in Alzheimer's disease.

Green tea extract delivers molecular punch to disrupt formation of neurotoxic species

October 11, 2017
Green tea is widely considered to be beneficial for the brain. The antioxidant and detoxifying properties of green tea extracts help fight catastrophic diseases such as Alzheimer's. However, scientists have never fully understood ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.